<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39327706</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1750-2659</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Influenza and other respiratory viruses</Title><ISOAbbreviation>Influenza Other Respir Viruses</ISOAbbreviation></Journal><ArticleTitle>Trends in Hospitalisations for Vaccine Preventable Respiratory Infections Following Emergency Department Presentations in New South Wales, Australia, 2012-2022.</ArticleTitle><Pagination><StartPage>e70015</StartPage><MedlinePgn>e70015</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e70015</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1111/irv.70015</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Vaccine-preventable respiratory infections impact on healthcare systems globally. Despite availability of vaccines, fluctuations in vaccination rates, pathogen virulence and community transmission dynamics mean that these respiratory infections continue to pose substantial public health risks. To understand trends in vaccine-preventable respiratory infections, we analysed linked data from emergency department (ED), hospitalisations and deaths in New South Wales, Australia, from 2012 to 2022.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">ED presentations with respiratory infection like illness were linked to hospitalisation and death records. Age-standardised rates of ED presentations, proportions subsequently hospitalised for acute respiratory infection (ARI) and specific vaccine-preventable disease diagnoses and 28-day mortality rates were estimated by year and age.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">From 2012 to 2022, there were 3,127,090 ARI-like ED presentations. Age-standardised rates increased until 2020, declined in 2021 and rebounded in 2022. Across all years, of these ARI-like ED presentations, 16.6% were hospitalised for acute respiratory infections, including pneumonia (7.9%), influenza (1.1%), RSV disease (1.3%), COVID-19 (0.8%) and pneumococcal disease (0.3%). Proportions hospitalised were highest in those aged 65+ years, except for RSV, which was highest in children aged 0-4 years. The highest 28-day mortality post-ARI-like ED presentation was observed with COVID-19 in adults aged 65+ years at 13.1%.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study highlights the continuing burden of vaccine-preventable respiratory infections on an Australian healthcare system. These data can be used to monitor the effectiveness of vaccination programmes and other public health interventions. Future efforts should focus on enhancing surveillance and data linkage to improve precision and guide targeted public health strategies.</AbstractText><CopyrightInformation>© 2024 The Author(s). Influenza and Other Respiratory Viruses published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hossain</LastName><ForeName>Fariha Binte</ForeName><Initials>FB</Initials><Identifier Source="ORCID">0000-0001-8017-8973</Identifier><AffiliationInfo><Affiliation>School of Population Health, UNSW Sydney, Kensington, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muscatello</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>School of Population Health, UNSW Sydney, Kensington, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jayasinghe</LastName><ForeName>Sanjay</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Centre for Immunisation Research and Surveillance (NCIRS), Kids Research, Sydney Children's Hospitals Network, Westmead, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Children's Hospital at Westmead Clinical School, The University of Sydney, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Bette</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>School of Population Health, UNSW Sydney, Kensington, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Centre for Immunisation Research and Surveillance (NCIRS), Kids Research, Sydney Children's Hospitals Network, Westmead, New South Wales, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Australian Government Research Training Program Scholarship</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Influenza Other Respir Viruses</MedlineTA><NlmUniqueID>101304007</NlmUniqueID><ISSNLinking>1750-2640</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009517" MajorTopicYN="N" Type="Geographic">New South Wales</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="Y">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="Y">Emergency Service, Hospital</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000079263" MajorTopicYN="N">Vaccine-Preventable Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute respiratory infections (ARI)</Keyword><Keyword MajorTopicYN="N">emergency department (ED) presentations</Keyword><Keyword MajorTopicYN="N">hospitalisation trends</Keyword><Keyword MajorTopicYN="N">vaccine‐preventable respiratory infection</Keyword></KeywordList><CoiStatement>One of the authors, David Muscatello, reports grants from the National Health and Medical Research Council (NHMRC), Australia, during the conduct of the study. Personal fees are from PAHO, WHO, and NSW Ministry of Health, outside the submitted work. Other authors have nothing to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>7</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>7</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39327706</ArticleId><ArticleId IdType="pmc">PMC11427497</ArticleId><ArticleId IdType="doi">10.1111/irv.70015</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Safiri S., Mahmoodpoor A., Kolahi A.‐A., et al., “Global Burden of Lower Respiratory Infections During the Last Three Decades,” Frontiers in Public Health 10 (2023): 1028525.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9869262</ArticleId><ArticleId IdType="pubmed">36699876</ArticleId></ArticleIdList></Reference><Reference><Citation>Troeger C., Blacker B., Khalil I. A., et al., “Estimates of the Global, Regional, and National Morbidity, Mortality, and Aetiologies of Lower Respiratory Infections in 195 Countries, 1990–2016: A Systematic Analysis for the Global Burden of Disease Study 2016,” Lancet Infectious Diseases 18, no. 11 (2018): 1191–1210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6202443</ArticleId><ArticleId IdType="pubmed">30243584</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J., Xie Z., Zhang T., et al., “Comparison of the Prevalence of Respiratory Viruses in Patients With Acute Respiratory Infections at Different Hospital Settings in North China, 2012–2015,” BMC Infectious Diseases 18, no. 1 (2018): 1–10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5806372</ArticleId><ArticleId IdType="pubmed">29422011</ArticleId></ArticleIdList></Reference><Reference><Citation>Lafond K. E., Porter R. M., Whaley M. J., et al., “Global Burden of Influenza‐Associated Lower Respiratory Tract Infections and Hospitalizations Among Adults: A Systematic Review and Meta‐Analysis,” PLoS Medicine 18, no. 3 (2021): e1003550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7959367</ArticleId><ArticleId IdType="pubmed">33647033</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Wang X., Blau D. M., et al., “Global, Regional, and National Disease Burden Estimates of Acute Lower Respiratory Infections Due to Respiratory Syncytial Virus in Children Younger Than 5 Years in 2019: A Systematic Analysis,” Lancet 399, no. 10340 (2022): 2047–2064.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7613574</ArticleId><ArticleId IdType="pubmed">35598608</ArticleId></ArticleIdList></Reference><Reference><Citation>Bender R. G., Sirota S. B., Swetschinski L. R., et al., “Global, Regional, and National Incidence and Mortality Burden of Non‐COVID‐19 Lower Respiratory Infections and Aetiologies, 1990–2021: A Systematic Analysis From the Global Burden of Disease Study 2021,” Lancet Infectious Diseases 24 (2024): 974–1002.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11339187</ArticleId><ArticleId IdType="pubmed">38636536</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization , “14.9 million excess deaths associated with the COVID‐19 pandemic in 2020 and 2021,” (2022).</Citation></Reference><Reference><Citation>Boyd J. H., Randall S. M., Ferrante A. M., et al., “Accuracy and Completeness of Patient Pathways—The Benefits of National Data Linkage in Australia,” BMC Health Services Research 15 (2015): 1–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4529694</ArticleId><ArticleId IdType="pubmed">26253452</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Williams E., and Kirk M., “Risk Factors for Acute Respiratory Infection in the Australian Community,” PLoS ONE 9, no. 7 (2014): e101440.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4102462</ArticleId><ArticleId IdType="pubmed">25032810</ArticleId></ArticleIdList></Reference><Reference><Citation>Irvine K., Hall R., and Taylor L., “A Profile of the Centre for Health Record Linkage,” International Journal of Population Data Science 4, no. 2 (2019): 1142.</Citation><ArticleIdList><ArticleId IdType="pubmed">34095543</ArticleId></ArticleIdList></Reference><Reference><Citation>“NSW Emergency Department Data Collection,”(2023).</Citation></Reference><Reference><Citation>Bureau of Health Information , “Technical Supplement‐Emergency Department, Ambulance, Admitted Patients, Seclusion and Restraint, and Elective Surgery,” (2022).</Citation></Reference><Reference><Citation>NSW Ministry of Health , “NSW Admitted Patient Data Collection,” (2020).</Citation></Reference><Reference><Citation>
Australian Bureau of Statistics
, “Population by Age and Sex, Regions of Australia,” 2016 2017, https://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/3235.02016.</Citation></Reference><Reference><Citation>
Australian Bureau of Statistics
, “1270.0.55.001 ‐ Australian Statistical Geography Standard (ASGS): Volume 1 ‐ Main Structure and Greater Capital City Statistical Areas,” July 2016 2016, https://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/1270.0.55.001July%202016?OpenDocument.</Citation></Reference><Reference><Citation>Muscatello D. J., Bein K. J., and Dinh M. M., “Emergency Department Demand Associated With Seasonal Influenza, 2010 Through 2014, New South Wales, Australia,” Western Pacific Surveillance and Response Journal: WPSAR 8, no. 3 (2017): 11–20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5635331</ArticleId><ArticleId IdType="pubmed">29051837</ArticleId></ArticleIdList></Reference><Reference><Citation>Australian Government DoH , “Australian Influenza Surveillance Report,” (2020).</Citation></Reference><Reference><Citation>NSW Government , “Influenza Surveillance Report March 2020,” (2020).</Citation></Reference><Reference><Citation>Jeffery M. M., D'onofrio G., Paek H., et al., “Trends in Emergency Department Visits and Hospital Admissions in Health Care Systems in 5 States in the First Months of the COVID‐19 Pandemic in the US,” JAMA Internal Medicine 180, no. 10 (2020): 1328–1333.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7400214</ArticleId><ArticleId IdType="pubmed">32744612</ArticleId></ArticleIdList></Reference><Reference><Citation>Australian Government AIoHaW , “Australian Burden of Disease Study 2022,” (2022).</Citation></Reference><Reference><Citation>Australian Government , “Access to PCR Testing from 1 January 2023,” (2023).</Citation></Reference><Reference><Citation>El‐Azami‐El‐Idrissi M., Lakhdar‐Idrissi M., Chaouki S., Atmani S., Bouharrou A., and Hida M., “Pediatric Recurrent Respiratory Tract Infections: When and How to Explore the Immune System? (About 53 Cases),” Pan African Medical Journal 24 (2016): 53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5012823</ArticleId><ArticleId IdType="pubmed">27642394</ArticleId></ArticleIdList></Reference><Reference><Citation>Fry M., Fitzpatrick L., Considine J., Shaban R. Z., and Curtis K., “Emergency Department Utilisation Among Older People With Acute and/or Chronic Conditions: A Multi‐Centre Retrospective Study,” International Emergency Nursing 37 (2018): 39–43.</Citation><ArticleIdList><ArticleId IdType="pubmed">27743877</ArticleId></ArticleIdList></Reference><Reference><Citation>
NSW Government
, “Acute Respiratory Infection Hospitalisations 2022,” https://www.healthstats.nsw.gov.au/indicator?name=‐res‐acuteresp‐hos&amp;location=PHN&amp;view=Trend&amp;measure=DSTRate&amp;groups=Acute%20respiratory%20infection,Age%20(years),Sex&amp;compare=Acute%20respiratory%20infection,Age%20(years),Sex&amp;filter=PHN,Central%20and%20Eastern%20Sydney%20PHN&amp;filter=Sex,Persons&amp;filter=Acute%20respiratory%20infection,All%20acute%20respiratory%20infection&amp;filter=Age%20(years),All%20ages.</Citation></Reference><Reference><Citation>Cohen R., Ashman M., Taha M.‐K., et al., “Pediatric Infectious Disease Group (GPIP) Position Paper on the Immune Debt of the COVID‐19 Pandemic in Childhood, How Can We Fill the Immunity gap?,” Infectious Diseases Now 51, no. 5 (2021): 418–423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8114587</ArticleId><ArticleId IdType="pubmed">33991720</ArticleId></ArticleIdList></Reference><Reference><Citation>Australian Government AIoHaW , “Emergency Department Care Activity,” (2023).</Citation></Reference><Reference><Citation>
NSW Government
, “Key Facts About NSW 2022,” https://www.nsw.gov.au/about‐nsw/key‐facts‐about‐nsw.</Citation></Reference><Reference><Citation>Al Rajeh A. M., Naser A. Y., Siraj R., et al., “Acute Upper Respiratory Infections Admissions in England and Wales,” Medicine 102, no. 21 (2023): e33616.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10219745</ArticleId><ArticleId IdType="pubmed">37233440</ArticleId></ArticleIdList></Reference><Reference><Citation>Duwalage K. I., Burkett E., White G., Wong A., and Thompson M. H., “Forecasting Daily Counts of Patient Presentations in Australian Emergency Departments Using Statistical Models With Time‐Varying Predictors,” Emergency Medicine Australasia 32, no. 4 (2020): 618–625.</Citation><ArticleIdList><ArticleId IdType="pubmed">32067361</ArticleId></ArticleIdList></Reference><Reference><Citation>Moa A., Trent M., and Menzies R., “Severity of the 2019 Influenza Season in Australia—A Comparison Between 2017 and 2019 H3N2 Influenza Seasons,” Global Biosecurity 1, no. 3 (2019): 10.31646.</Citation></Reference><Reference><Citation>NSW GOVERNMENT , “The 2017 NSW Influenza Season,” (2019).</Citation></Reference><Reference><Citation>Nazareno A. L., Muscatello D. J., Turner R. M., Wood J. G., Moore H. C., and Newall A. T., “Modelled Estimates of Hospitalisations Attributable to Respiratory Syncytial Virus and Influenza in Australia, 2009–2017,” Influenza and Other Respiratory Viruses 16, no. 6 (2022): 1082–1090.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9530581</ArticleId><ArticleId IdType="pubmed">35775106</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan S. G., Chilver M. B., Carville K. S., et al., “Low Interim Influenza Vaccine Effectiveness, Australia, 1 May to 24 September 2017,” Eurosurveillance 22, no. 43 (2017): 17–00707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5718387</ArticleId><ArticleId IdType="pubmed">29090681</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamson E., Forbes C., Wittkopf P., et al., “Impact of Pandemics and Disruptions to Vaccination on Infectious Diseases Epidemiology Past and Present,” Human Vaccines &amp; Immunotherapeutics 19, no. 2 (2023): 2219577.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10332206</ArticleId><ArticleId IdType="pubmed">37291691</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams P. C., Howard‐Jones A., Butters C., et al., “Clinical and Epidemiologic Profile of Invasive Pneumococcal Disease in Australian Children Following the Relaxation of Nonpharmaceutical Interventions Against SARS‐COV‐2,” Pediatric Infectious Disease Journal 42, no. 9 (2023): e341–e342.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10627390</ArticleId><ArticleId IdType="pubmed">37200512</ArticleId></ArticleIdList></Reference><Reference><Citation>
Australian Government DoHaAC
, “National Immunisation Program – Pneumococcal Vaccination Schedule From 1 July 2020 – Clinical Decision Tree for Vaccination Providers 2020, https://www.health.gov.au/resources/publications/national‐immunisation‐program‐pneumococcal‐vaccination‐schedule‐from‐1‐july‐2020‐clinical‐decision‐tree‐for‐vaccination‐providers?language=en.</Citation></Reference><Reference><Citation>Korsun N., Trifonova I., Madzharova I., et al., “Resurgence of Respiratory Syncytial Virus With Dominance of RSV‐B During the 2022–2023 Season,” Frontiers in Microbiology 15 (2024): 1376389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11019023</ArticleId><ArticleId IdType="pubmed">38628867</ArticleId></ArticleIdList></Reference><Reference><Citation>Suss R. J. and Simões E. A., “Respiratory Syncytial Virus Hospital‐Based Burden of Disease in Children Younger Than 5 Years, 2015‐2022,” JAMA Network Open 7, no. 4 (2024): e247125‐e.</Citation><ArticleIdList><ArticleId IdType="pubmed">38635270</ArticleId></ArticleIdList></Reference><Reference><Citation>Foley D. A., Yeoh D. K., Minney‐Smith C. A., et al., “The Interseasonal Resurgence of Respiratory Syncytial Virus in Australian Children Following the Reduction of Coronavirus Disease 2019–Related Public Health Measures,” Clinical Infectious Diseases 73, no. 9 (2021): e2829–e2830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7929151</ArticleId><ArticleId IdType="pubmed">33594407</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>